drugset / Trial / NCT01805115
Misoprostol Administration Before Operative Hysteroscopy
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to compare the efficacy of oral, sublingual, vaginal, and no misoprostol prior to operative hysteroscopy in premenopausal women.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-01
- Completion
- 2014-02
Outcome
Met primary endpoint
paper The mean (±SD) cervical widths for the oral, sublingual, vaginal, and control groups were 7.62±1.81 mm, 7.58±1.77 mm, 7.60±2.15 mm, and 5.65±2.12 mm, respectively, which was statistically significant. PMID 24856464 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 400 ug | Oral |